CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-12 | Cotreau Violetta SVP, Chief Accounting Officer | Grant or award | +150,000 | 219,954 | ||
| 2022-03-01 | Butler John P. CEO and President | Sale | −24,811 | $2.17 | $54K | 1,432,409 |
| 2022-03-01 | Butler John P. CEO and President | Sale | −25,031 | $2.17 | $54K | 1,407,378 |
| 2022-03-01 | Butler John P. CEO and President | Sale | −4,131 | $2.17 | $9K | 1,403,247 |
| 2022-03-01 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −6,556 | $2.17 | $14K | 217,263 |
| 2022-03-01 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −1,100 | $2.17 | $2K | 217,663 |
| 2022-03-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −6,873 | $2.17 | $15K | 302,122 |
| 2022-03-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −6,873 | $2.17 | $15K | 295,249 |
| 2022-03-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −1,232 | $2.17 | $3K | 297,017 |
| 2022-03-01 | Faulkingham Dell SVP, CCO | Sale | −5,748 | $2.17 | $12K | 174,798 |
| 2022-03-01 | Faulkingham Dell SVP, CCO | Sale | −957 | $2.17 | $2K | 173,841 |
| 2022-03-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −6,873 | $2.17 | $15K | 308,875 |
| 2022-03-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −6,556 | $2.17 | $14K | 302,319 |
| 2022-03-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −1,078 | $2.17 | $2K | 304,241 |
| 2022-03-01 | Spellman David A SVP, CFO and Treasurer | Sale | −803 | $2.17 | $2K | 128,599 |
| 2022-02-28 | Butler John P. CEO and President | Sale | −25,053 | $2.15 | $54K | 1,164,095 |
| 2022-02-28 | Butler John P. CEO and President | Grant or award | +293,125 | 1,457,220 | ||
| 2022-02-28 | Butler John P. CEO and President | Grant or award · Employee Stock Option (Right to buy) | +739,700 | 739,700 | ||
| 2022-02-28 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −7,400 | $2.15 | $16K | 163,819 |
| 2022-02-28 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award | +60,000 | 223,819 |
Page 11 of 21 · 405 trades